3-((4-AMINO-2-METHYL-5-PYRIMIDINYL)METHYL)-4-METHYL-5-(2-(METHYLTHIO)ETHYL)THIAZOLIUM
UNII RAP5VR8LGQ
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(2-(methylthio)ethyl)thiazolium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RAP5VR8LGQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 686701-71-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C13H19N4S2 VUDHTOQWNRYDKV-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-4-methyl-5-(2-(methylthio)ethyl)thiazolium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.